These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20373880)

  • 1. Nona-D-arginine amide for prophylaxis and treatment of experimental Pseudomonas aeruginosa keratitis.
    Karicherla P; Hobden JA
    Curr Eye Res; 2010 Mar; 35(3):220-4. PubMed ID: 20373880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nona-D-arginine therapy for Pseudomonas aeruginosa keratitis.
    Karicherla P; Hobden JA
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):256-62. PubMed ID: 18775859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit.
    Levy JH; Katz HR
    Ann Ophthalmol; 1990 May; 22(5):179-83. PubMed ID: 2114813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
    Jensen H; Zerouala C; Carrier M; Short B
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineural infiltrates in Pseudomonas keratitis.
    Robbie SJ; Vega FA; Tint NL; Hau S; Allan B
    J Cataract Refract Surg; 2013 Nov; 39(11):1764-7. PubMed ID: 24160385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas keratitis.
    Yilmaz S; Saklamaz A; Maden A
    Ophthalmology; 2006 May; 113(5):883-4. PubMed ID: 16650685
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiresistant Pseudomonas keratitis.
    Ku JY; Kim P; Tong J; Wechsler A; McCluskey P
    Clin Exp Ophthalmol; 2010 Nov; 38(8):818-9. PubMed ID: 20572829
    [No Abstract]   [Full Text] [Related]  

  • 14. In Vitro Antibiotic Susceptibility of Pseudomonas aeruginosa Corneal Ulcer Isolates.
    Gupta S; Mittal S; Nayak N; Satpathy G; Khokhar S; Agarwal T
    Ocul Immunol Inflamm; 2015 Jun; 23(3):252-5. PubMed ID: 24564536
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudomonas keratitis after laser in situ keratomileusis.
    Sharma N; Sinha R; Singhvi A; Tandon R
    J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
    Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
    Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas keratitis associated with continuous wear silicone-hydrogel soft contact lens: a case report.
    Lee KY; Lim L
    Eye Contact Lens; 2003 Oct; 29(4):255-7. PubMed ID: 14555905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spantide I decreases type I cytokines, enhances IL-10, and reduces corneal perforation in susceptible mice after Pseudomonas aeruginosa infection.
    Hazlett LD; McClellan SA; Barrett RP; Liu J; Zhang Y; Lighvani S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):797-807. PubMed ID: 17251480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of a pseudomonas corneal ulcer in an occasional use daily disposable contact lens wearer.
    Munneke R; Lash SC; Prendiville C
    Eye Contact Lens; 2006 Mar; 32(2):94-5. PubMed ID: 16538131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
    Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.